Dudediligence.

Adaptive Biotechnologies Corporation

ADPTNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Insiders

Last 12 months

Sales planned on beside the trades reported on , and whether each names a .

Planned ·

$171.2M

71 notices · 8,790,047 sh

Oct 2025 to Oct 2026

Reported ·

$70.9M

99 sales · 0 buys

Oct 2025 to Jun 2026

The two figures cover different periods.

87 of 99 reported sales carry the 10b5-1 box. Together they are 2.90% of the shares on issue.

PLANNED · FORM 144Oct 2025 to Oct 2026REPORTED · FORM 4Oct 2025 to Jun 2026N2025DJ2026FMAMJJASO2026-10-01: JULIE RUBINSTEIN, Form 1442026-09-16: FRANCIS LO, Form 1442026-09-15: SUSAN BOBULSKY, Form 1442026-08-26: KATHERINE E OWEN, Form 1442026-08-20: Harlan Robins, Form 1442026-08-19: Harlan Robins, Form 1442026-08-18: Chad Robins, Form 1442026-08-18: Harlan Robins, Form 1442026-08-18: ROBERT M HERSHBERG, Form 1442026-08-17: Harlan Robins, Form 1442026-08-17: Chad Robins, Form 1442026-08-17: PETER NEUPERT, Form 1442026-08-10: SUSAN BOBULSKY, Form 1442026-07-30: SUSAN BOBULSKY, Form 1442026-07-21: Harlan Robins, Form 1442026-07-16: SUSAN BOBULSKY, Form 1442026-07-02: Harlan Robins, Form 1442026-07-01: FRANCIS LO, Form 1442026-07-01: SUSAN BOBULSKY, Form 1442026-06-29: SHARON BENZENO, Form 1442026-06-26: SHARON BENZENO, Form 1442026-06-25: SUSAN BOBULSKY, Form 1442026-06-25: MICHELLE GRIFFIN, Form 1442026-06-16: Harlan Robins, Form 1442026-06-15: Harlan Robins, Form 1442026-06-11: SUSAN BOBULSKY, Form 1442026-06-04: SUSAN BOBULSKY, Form 1442026-06-04: FRANCIS LO, Form 1442026-05-18: PISKEL KYLE, Form 1442026-04-08: Harlan Robins, Form 1442026-04-08: Chad Robins, Form 1442026-04-08: FRANCIS LO, Form 1442026-04-06: Chad Robins, Form 1442026-03-11: BOBULSKY SUSAN, Form 1442026-03-11: BENZENO SHARON, Form 1442026-03-11: ROBINS HARLAN S, Form 1442026-03-11: RUBINSTEIN JULIE, Form 1442026-03-11: PISKEL KYLE, Form 1442026-03-11: ROBINS CHAD M, Form 1442026-03-11: FRANCIS LO, Form 1442026-03-11: MICHELLE GRIFFIN, Form 1442026-03-05: LO FRANCIS, Form 1442026-03-03: Harlan Robins, Form 1442026-03-03: Chad Robins, Form 1442026-03-03: JULIE RUBINSTEIN, Form 1442026-03-03: MICHELLE GRIFFIN, Form 1442026-03-02: Harlan Robins, Form 1442026-03-02: Chad Robins, Form 1442026-02-27: Chad Robins, Form 1442026-02-03: Harlan Robins, Form 1442026-02-02: Harlan Robins, Form 1442026-02-02: Chad Robins, Form 1442026-01-12: FRANCIS LO, Form 1442026-01-12: KYLE PISKEL, Form 1442026-01-06: Harlan Robins, Form 1442026-01-05: Chad Robins, Form 1442025-12-15: FRANCIS LO, Form 1442025-12-10: ROBERT M HERSHBERG, Form 1442025-12-04: Harlan Robins, Form 1442025-12-04: SHARON BENZENO, Form 1442025-12-03: Harlan Robins, Form 1442025-12-01: Chad Robins, Form 1442025-11-28: KYLE PISKEL, Form 1442025-11-26: Chad Robins, Form 1442025-11-21: BENZENO SHARON, Form 1442025-11-20: SHARON BENZENO, Form 1442025-11-19: SHARON BENZENO, Form 1442025-11-12: Chad Robins, Form 1442025-11-11: Chad Robins, Form 1442025-11-10: Chad Robins, Form 1442025-11-10: Harlan Robins, Form 1442025-11-10: ROBINS CHAD M, sold2025-11-10: ROBINS HARLAN S, sold2025-11-17: PISKEL KYLE, sold2025-11-20: BENZENO SHARON, sold2025-11-26: ROBINS CHAD M, sold2025-11-28: PISKEL KYLE, sold2025-12-03: ROBINS HARLAN S, sold2025-12-04: BENZENO SHARON, sold2025-12-10: HERSHBERG ROBERT, sold2025-12-15: LO FRANCIS, sold2025-12-22: LO FRANCIS, sold2026-01-02: LO FRANCIS, sold2026-01-05: ROBINS CHAD M, sold2026-01-06: ROBINS HARLAN S, sold2026-01-12: LO FRANCIS, sold2026-01-12: PISKEL KYLE, sold2026-02-02: ROBINS CHAD M, sold2026-02-02: ROBINS HARLAN S, sold2026-02-04: PISKEL KYLE, sold2026-02-27: ROBINS CHAD M, sold2026-03-02: ROBINS HARLAN S, sold2026-03-03: GRIFFIN MICHELLE RENEE, sold2026-03-03: RUBINSTEIN JULIE, sold2026-03-05: LO FRANCIS, sold2026-03-06: RUBINSTEIN JULIE, sold2026-03-11: GRIFFIN MICHELLE RENEE, sold2026-03-11: ROBINS CHAD M, sold2026-03-11: LO FRANCIS, sold2026-03-11: PISKEL KYLE, sold2026-03-11: RUBINSTEIN JULIE, sold2026-03-11: ROBINS HARLAN S, sold2026-03-11: BENZENO SHARON, sold2026-03-11: BOBULSKY SUSAN, sold2026-03-16: RUBINSTEIN JULIE, sold2026-03-19: RUBINSTEIN JULIE, sold2026-03-24: RUBINSTEIN JULIE, sold2026-03-27: RUBINSTEIN JULIE, sold2026-04-01: RUBINSTEIN JULIE, sold2026-04-06: ROBINS CHAD M, sold2026-04-06: RUBINSTEIN JULIE, sold2026-04-08: LO FRANCIS, sold2026-04-08: ROBINS HARLAN S, sold2026-04-09: RUBINSTEIN JULIE, sold2026-04-14: RUBINSTEIN JULIE, sold2026-04-17: RUBINSTEIN JULIE, sold2026-04-22: RUBINSTEIN JULIE, sold2026-04-27: RUBINSTEIN JULIE, sold2026-05-18: PISKEL KYLE, sold2026-06-04: LO FRANCIS, sold2026-06-04: BOBULSKY SUSAN, sold2026-06-11: BOBULSKY SUSAN, sold2026-06-15: ROBINS HARLAN S, sold
under a no plan named▼ salesize is dollars

Form 144 notices, newest first

2026-10-01JULIE RUBINSTEIN, President and COO$11.0M
379,777 shplan 2025-11-18Form 4s on file end Jun 23144 ↗
2026-09-16FRANCIS LO, Chief People Officer$3,793,843
142,198 shplan 2025-09-15Form 4s on file end Jun 23144 ↗
2026-09-15SUSAN BOBULSKY, Chief Commercial Officer, MRD$29,612
1,195 shplan 2025-12-16Form 4s on file end Jun 23144 ↗
2026-08-26KATHERINE E OWEN, Director$249,990
9,615 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-20Harlan Robins, Chief Scientific Officer$10.2M
402,160 shplan 2026-03-13Form 4s on file end Jun 23144 ↗
2026-08-19Harlan Robins, Chief Scientific Officer$5,496,460
215,632 shplan 2026-03-13Form 4s on file end Jun 23144 ↗
2026-08-18Chad Robins, CEO and Chairman$6,844,283
278,676 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-18Harlan Robins, Chief Scientific Officer$6,411,241
261,044 shplan 2026-03-13Form 4s on file end Jun 23144 ↗
2026-08-18ROBERT M HERSHBERG, Director$748,303
30,664 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-17Harlan Robins, Chief Scientific Officer$7,455,572
300,992 shplan 2026-03-13Form 4s on file end Jun 23144 ↗
2026-08-17Chad Robins, CEO and Chairman$7,959,195
321,324 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-17PETER NEUPERT, Director$3,136,046
124,690 shno plan dateForm 4s on file end Jun 23144 ↗
2026-08-10SUSAN BOBULSKY, Chief Commercial Officer, MRD$74,790
3,000 shplan 2025-12-16Form 4s on file end Jun 23144 ↗
2026-07-30SUSAN BOBULSKY, Chief Commercial Officer, MRD$29,305
1,299 shplan 2025-12-16Form 4s on file end Jun 23144 ↗
2026-07-21Harlan Robins, Chief Scientific Officer$11.1M
492,400 shplan 2026-03-13Form 4s on file end Jun 23144 ↗
2026-07-16SUSAN BOBULSKY, Chief Commercial Officer, MRD$114,500
5,000 shplan 2025-12-16Form 4s on file end Jun 23144 ↗
2026-07-02Harlan Robins, Chief Scientific Officer$8,184,426
386,240 shplan 2026-03-13Form 4s on file end Jun 23144 ↗
2026-07-01FRANCIS LO, Chief People Officer$4,274,127
199,260 shplan 2025-09-15Form 4s on file end Jun 23144 ↗
2026-07-01SUSAN BOBULSKY, Chief Commercial Officer, MRD$10,446
487 shplan 2025-12-16Form 4s on file end Jun 23144 ↗
2026-06-29SHARON BENZENO, Chief Commercial Ofc Imm Med$3,205,434
152,931 shplan 2025-12-12Form 4s on file end Jun 23144 ↗
2026-06-26SHARON BENZENO, Chief Commercial Ofc Imm Med$260,638
12,871 shplan 2025-12-12144 ↗
Form 4, 2026-06-30: sold 165,802 at $21.13 Form 4 ↗
2026-06-25SUSAN BOBULSKY, Chief Commercial Officer, MRD$96,700
5,000 shplan 2025-12-16144 ↗
Form 4, 2026-06-29: sold 5,000 at $20.50 Form 4 ↗
2026-06-25MICHELLE GRIFFIN, Director$1,007,305
52,084 shplan 2025-11-07144 ↗
Form 4, 2026-06-29: sold 52,084 at $20.18 Form 4 ↗
2026-06-16Harlan Robins, Chief Scientific Officer$106,075
6,160 shplan 2026-03-13Form 4s on file end Jun 23144 ↗
2026-06-15Harlan Robins, Chief Scientific Officer$1,746,000
100,000 shplan 2026-03-13144 ↗
Form 4, 2026-06-17: sold 106,160 at $17.41 Form 4 ↗
2026-06-11SUSAN BOBULSKY, Chief Commercial Officer, MRD$85,350
5,000 shplan 2025-12-16144 ↗
Form 4, 2026-06-15: sold 5,000 at $19.00 Form 4 ↗
2026-06-04SUSAN BOBULSKY, Chief Commercial Officer, MRD$175,890
11,000 shplan 2025-12-16144 ↗
Form 4, 2026-06-08: sold 11,000 at $18.00 Form 4 ↗
2026-06-04FRANCIS LO, Chief People Officer$672,939
42,085 shplan 2025-09-15144 ↗
Form 4, 2026-06-08: sold 39,741 at $17.49 Form 4 ↗
2026-05-18PISKEL KYLE, Chief Financial Officer$40,543
3,160 shno plan date144 ↗
Form 4, 2026-05-20: sold 3,115 at $13.04 Form 4 ↗
2026-04-08Harlan Robins, Chief Scientific Officer$148,400
10,000 shplan 2025-08-11144 ↗
Form 4, 2026-04-10: sold 10,000 at $14.85 Form 4 ↗
2026-04-08Chad Robins, CEO and Chairman$552,983
37,263 shplan 2025-08-11Form 4s on file end Jun 23144 ↗
2026-04-08FRANCIS LO, Chief People Officer$309,352
22,564 shplan 2025-09-15144 ↗
Form 4, 2026-04-10: sold 22,564 at $15.07 Form 4 ↗
2026-04-06Chad Robins, CEO and Chairman$1,173,315
83,332 shplan 2025-08-11144 ↗
Form 4, 2026-04-08: sold 120,595 at $14.65 Form 4 ↗
2026-03-11BOBULSKY SUSAN, Chief Commercial Officer, MRD$600,228
41,338 shplan 2025-12-16144 ↗
Form 4, 2026-03-13: sold 41,338 at $13.17 Form 4 ↗
2026-03-11BENZENO SHARON, Chief Commercial Ofc Imm Med$916,256
63,103 shplan 2025-12-12144 ↗
Form 4, 2026-03-13: sold 63,103 at $13.17 Form 4 ↗
2026-03-11ROBINS HARLAN S, Chief Scientific Officer$6,828,262
470,266 shplan 2025-08-11144 ↗
Form 4, 2026-03-13: sold 470,266 at $13.17 Form 4 ↗
2026-03-11RUBINSTEIN JULIE, President and COO$1,779,034
122,523 shplan 2025-11-18144 ↗
Form 4, 2026-03-13: sold 179,703 at $13.21 Form 4 ↗
2026-03-11PISKEL KYLE, Chief Financial Officer$271,117
18,672 shplan 2025-08-28144 ↗
Form 4, 2026-03-13: sold 18,672 at $13.17 Form 4 ↗
2026-03-11ROBINS CHAD M, CEO and Chairman$6,826,825
470,167 shplan 2025-08-11144 ↗
Form 4, 2026-03-13: sold 470,167 at $13.17 Form 4 ↗
2026-03-11FRANCIS LO, Chief People Officer$444,210
30,593 shplan 2025-09-15144 ↗
Form 4, 2026-03-13: sold 30,593 at $14.08 Form 4 ↗
2026-03-11MICHELLE GRIFFIN, Director$214,097
15,394 shplan 2025-11-07144 ↗
Form 4, 2026-03-13: sold 15,394 at $13.91 Form 4 ↗
2026-03-05LO FRANCIS, Chief People Officer$625,937
38,074 shplan 2025-09-15144 ↗
Form 4, 2026-03-09: sold 38,074 at $15.09 Form 4 ↗
2026-03-03Harlan Robins, Chief Scientific Officer$228,867
14,233 shplan 2025-08-11no Form 4 on file144 ↗
2026-03-03Chad Robins, CEO and Chairman$853,575
53,083 shplan 2025-08-11no Form 4 on file144 ↗
2026-03-03JULIE RUBINSTEIN, President and COO$19.5M
1,206,661 shplan 2025-11-18144 ↗
Form 4, 2026-03-05: sold 92,823 at $16.09 Form 4 ↗
2026-03-03MICHELLE GRIFFIN, Director$774,469
48,044 shplan 2025-11-07144 ↗
Form 4, 2026-03-05: sold 48,044 at $15.30 Form 4 ↗
2026-03-02Harlan Robins, Chief Scientific Officer$161,200
10,000 shplan 2025-08-11144 ↗
Form 4, 2026-03-04: sold 24,233 at $16.19 Form 4 ↗
2026-03-02Chad Robins, CEO and Chairman$4,659,067
289,024 shplan 2025-08-11no Form 4 on file144 ↗
2026-02-27Chad Robins, CEO and Chairman$2,929,914
182,891 shplan 2025-08-11144 ↗
Form 4, 2026-03-03: sold 524,998 at $15.85 Form 4 ↗
2026-02-03Harlan Robins, Chief Scientific Officer$150,220
8,120 shplan 2025-08-11no Form 4 on file144 ↗
2026-02-02Harlan Robins, Chief Scientific Officer$637,545
34,668 shplan 2025-08-11144 ↗
Form 4, 2026-02-04: sold 42,788 at $18.68 Form 4 ↗
2026-02-02Chad Robins, CEO and Chairman$2,298,713
124,998 shplan 2025-08-11144 ↗
Form 4, 2026-02-04: sold 124,998 at $18.44 Form 4 ↗
2026-01-12FRANCIS LO, Chief People Officer$1,013,258
64,293 shplan 2025-09-15144 ↗
Form 4, 2026-01-14: sold 79,590 at $17.73 Form 4 ↗
2026-01-12KYLE PISKEL, Chief Financial Officer$174,637
11,081 shplan 2025-08-28144 ↗
Form 4, 2026-01-14: sold 4,290 at $18.00 Form 4 ↗
2026-01-06Harlan Robins, Chief Scientific Officer$161,100
10,000 shplan 2025-08-11144 ↗
Form 4, 2026-01-08: sold 10,000 at $16.44 Form 4 ↗
2026-01-05Chad Robins, CEO and Chairman$2,021,218
124,998 shplan 2025-08-11144 ↗
Form 4, 2026-01-07: sold 124,998 at $15.59 Form 4 ↗
2025-12-15FRANCIS LO, Chief People Officer$2,110,741
136,706 shplan 2025-09-15144 ↗
Form 4, 2025-12-17: sold 113,890 at $15.57 Form 4 ↗
2025-12-10ROBERT M HERSHBERG, Director$367,488
22,968 shno plan date144 ↗
Form 4, 2025-12-12: sold 22,968 at $16.00 Form 4 ↗
2025-12-04Harlan Robins, Chief Scientific Officer$174,600
10,000 shplan 2025-08-11no Form 4 on file144 ↗
2025-12-04SHARON BENZENO, Chief Commercial Ofc Imm Med$215,907
12,604 shplan 2025-08-18144 ↗
Form 4, 2025-12-08: sold 12,604 at $16.85 Form 4 ↗
2025-12-03Harlan Robins, Chief Scientific Officer$466,142
27,212 shplan 2025-08-11144 ↗
Form 4, 2025-12-05: sold 37,212 at $18.07 Form 4 ↗
2025-12-01Chad Robins, CEO and Chairman$2,354,962
124,998 shplan 2025-08-11no Form 4 on file144 ↗
2025-11-28KYLE PISKEL, Chief Financial Officer$3,210,810
162,820 shplan 2025-08-28144 ↗
Form 4, 2025-12-02: sold 162,820 at $19.50 Form 4 ↗
2025-11-26Chad Robins, CEO and Chairman$704,714
35,736 shplan 2025-08-11144 ↗
Form 4, 2025-12-01: sold 160,734 at $19.10 Form 4 ↗
2025-11-21BENZENO SHARON, Chief Commercial Ofc Imm Med$5,034,345
308,477 shplan 2025-08-18no Form 4 on file144 ↗
2025-11-20SHARON BENZENO, Chief Commercial Ofc Imm Med$3,060,194
201,993 shplan 2025-08-18144 ↗
Form 4, 2025-11-24: sold 606,402 at $16.73 Form 4 ↗
2025-11-19SHARON BENZENO, Chief Commercial Ofc Imm Med$1,319,065
95,932 shplan 2025-08-18no Form 4 on file144 ↗
2025-11-12Chad Robins, CEO and Chairman$27,202
1,876 shplan 2025-08-11no Form 4 on file144 ↗
2025-11-11Chad Robins, CEO and Chairman$17,974
1,237 shplan 2025-08-11no Form 4 on file144 ↗
2025-11-10Chad Robins, CEO and Chairman$1,267,428
86,161 shplan 2025-08-11144 ↗
Form 4, 2025-11-12: sold 89,265 at $14.73 Form 4 ↗
2025-11-10Harlan Robins, Chief Scientific Officer$147,100
10,000 shplan 2025-08-11144 ↗
Form 4, 2025-11-12: sold 10,000 at $14.82 Form 4 ↗